Digestive Symptoms in Healthy People and Subjects With Irritable Bowel Syndrome

Goals: The aim of this study was to validate the ability of symptom frequency questionnaire to differentiate between irritable bowel syndrome (IBS) patients and healthy subjects. Background: A digestive symptom frequency questionnaire (DSFQ) was previously used in a food efficacy trial in a non-IBS population with mild gastrointestinal symptoms. Study: We compared 2 well-defined populations: 100 IBS patients fulfilling Rome III criteria (mean age 32 y; range, 18 to 59 y), and 100 sex-matched and age-matched healthy subjects. Frequency of individual digestive symptoms (abdominal pain/discomfort, bloating, flatulence, borborygmi) was assessed using a 5-point Likert scale (from none to everyday of the week) and the IBS severity with the IBS-SSS questionnaire. Health-Related Quality of life (HRQoL) was assessed with the Food and Benefits Assessment (FBA) and Functional Digestive Disorders Quality of Life (FDDQL) questionnaires. The digestive (dis)comfort dimension of these questionnaires was considered as the main dimension for HRQoL. Results: The DSFQ discriminated IBS from healthy subjects with a significant difference (P<0.001) between groups (estimated mean difference=5.58; 95% CI, 4.91-6.28). On the basis of the ROC curve (AUC=0.9479), a cutoff value of 5 gives a sensitivity of 92% and a specificity of 84%, with a positive likelihood ratio of 5.75. Composite score of symptoms correlated strongly (P<0.0001) with digestive discomfort measured by FDDQL (−0.816), digestive comfort measured by FBA (−0.789), and the IBS-SSS score (0.762). Conclusions: Measurement of digestive symptom frequency by means of the DSFQ can differentiate IBS from healthy subjects, and shows a good correlation with other validated questionnaires (clinical trial #NCT01457378).

[1]  Lin Chang,et al.  FUNCTIONAL BOWEL DISORDERS , 2018, The American Journal of Gastroenterology.

[2]  M. V. van Oijen,et al.  Gastrointestinal Symptoms are Still Prevalent and Negatively Impact Health-Related Quality of Life: A Large Cross-Sectional Population Based Study in The Netherlands , 2013, PloS one.

[3]  D. Guyonnet,et al.  A randomized, double‐blind, controlled study and pooled analysis of two identical trials of fermented milk containing probiotic Bifidobacterium lactis CNCM I‐2494 in healthy women reporting minor digestive symptoms , 2013, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[4]  O. Chassany,et al.  Gastrointestinal well-being in subjects reporting mild gastrointestinal discomfort: characteristics and properties of a global assessment measure. , 2013, The British journal of nutrition.

[5]  H. van Loveren,et al.  Probiotics and prebiotics: health claim substantiation , 2012, Microbial ecology in health and disease.

[6]  H. Mönnikes.  Quality of Life in Patients With Irritable Bowel Syndrome , 2011, Journal of clinical gastroenterology.

[7]  Efsa Panel on Dietetic Products.  Guidance on the scientific requirements for health claims related to gut and immune function , 2011 .

[8]  W. Chey,et al.  Measuring symptoms in the irritable bowel syndrome: development of a framework for clinical trials , 2010, Alimentary pharmacology & therapeutics.

[9]  W. Chey,et al.  Characterizing abdominal pain in IBS: guidance for study inclusion criteria, outcome measurement and clinical practice , 2010, Alimentary pharmacology & therapeutics.

[10]  W. Chey,et al.  Measuring irritable bowel syndrome patient‐reported outcomes with an abdominal pain numeric rating scale , 2009, Alimentary pharmacology & therapeutics.

[11]  O. Chassany,et al.  Fermented milk containing Bifidobacterium lactis DN-173 010 improves gastrointestinal well-being and digestive symptoms in women reporting minor digestive symptoms: a randomised, double-blind, parallel, controlled study , 2009, British Journal of Nutrition.

[12]  O. Chassany,et al.  Perceived subject outcomes and impact on health-related quality of life associated with diet using the new Food Benefits Assessment (FBA©) questionnaire: development and psychometric validation , 2008, Public Health Nutrition.

[13]  I. Wiklund,et al.  Quality of life in patients with endoscopy-negative heartburn: reliability and sensitivity of disease-specific instruments , 2001, American Journal of Gastroenterology.

[14]  P. Fayers,et al.  Quality of Life: Assessment, Analysis, and Interpretation , 2000 .

[15]  O. Chassany,et al.  Validation of a specific quality of life questionnaire for functional digestive disorders , 1999, Gut.

[16]  P. Denis,et al.  Etude descriptive des symptômes fonctionnels digestifs dans la population générale française. , 1998 .

[17]  P. Whorwell,et al.  The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress , 1997, Alimentary pharmacology & therapeutics.

[18]  Nicholas J. Talley,et al.  U. S. Householder survey of functional gastrointestinal disorders , 1993, Digestive Diseases and Sciences.

[19]  L. D. O'Donnell,et al.  Symptoms of irritable bowel syndrome in a British urban community: consulters and nonconsulters. , 1992, Gastroenterology.

[20]  I. Dreosti,et al.  Blood copper as an indicator of copper status with a note on serum proteins and leucocyte counts in copper-deficient rats , 1968, British Journal of Nutrition.

[21]  G. Pickering.  The concept of essential hypertension. , 1955, Annals of internal medicine.

[22]  EFSA on Dietetic Products, Nutrition and Allergies (NDA); Scientific Opinion on the substantiation of a health claim related to vitamin K2 and to the normal function of the heart and blood vessels (ID further assessment) pursuant to 13(1) , 2012 .

[23]  M. V. van Oijen,et al.  Gastrointestinal symptoms are still common in a general Western population. , 2008, The Netherlands journal of medicine.

[24]  J. Malagelada,et al.  Abdominal bloating. , 2005, Gastroenterology.

[25]  I. Wiklund,et al.  Reliability and validity of the gastrointestinal symptom rating scale in patients with gastroesophageal reflux disease , 2004, Quality of Life Research.

[26]  H. Allemand,et al.  [Descriptive study of digestive functional symptoms in the French general population]. , 1998, Gastroenterologie clinique et biologique.